跳转至内容
Merck

T5824

Sigma-Aldrich

TAN-67 dihydrobromide

≥98% (HPLC), solid

别名:

(3-Hydroxyphenyl)-1,2,3,4,4a,5,12,12aa-octahydroquinolino[2,3,3-g]isoquinoline dihydrobromide, SB-205607 dihydrobromide

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C23H24N2O · 2HBr
分子量:
506.27
MDL號碼:
分類程式碼代碼:
12352200

描述

Store tightly sealed under nitrogen

化驗

≥98% (HPLC)

形狀

solid

顏色

off-white

溶解度

H2O: soluble >20 mg/mL

儲存溫度

2-8°C

SMILES 字串

Br[H].Br[H].[H][C@@]12CN(C)CC[C@]1(Cc3nc4ccccc4cc3C2)c5cccc(O)c5

生化/生理作用

Potent, selective non-peptide δ opioid receptor agonist.

法律資訊

Sold for research purposes under agreement from Glaxo­Smith­Kline

儲存類別代碼

13 - Non Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)


从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Hemal H Patel et al.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 16(11), 1468-1470 (2002-09-03)
Opioids and volatile anesthetics produce marked cardioprotective effects against myocardial infarction via the activation of ATP-sensitive potassium (K(ATP)) channels, however, the effect of combined treatment with both drugs is unknown. We examined the hypothesis that opioids and volatile anesthetics potentiate
R M Fryer et al.
The Journal of pharmacology and experimental therapeutics, 299(2), 477-482 (2001-10-17)
We investigated the possibility that opioids activate a tyrosine kinase (TK) that mediates cardioprotection in an in vivo rat model of myocardial infarction. All animals underwent 30 min of regional ischemia and 2 h of reperfusion. Infarct size was expressed

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门